Lassa mammarenavirus envelope glycoprotein

Product list
Mammarenaviruses, including lethal pathogens such as Lassa virus and Junín virus, can cause severe hemorrhagic fever in humans. Entry is a key step for virus infection, which starts with binding of the envelope glycoprotein (GP) to receptors on target cells and subsequent fusion of the virus with target cell membranes. The GP precursor is synthesized as a polypeptide, and maturation occurs by two cleavage events, yielding a tripartite GP complex (GPC) formed by a stable signal peptide (SSP), GP1 and GP2. The unique retained SSP interacts with GP2 and plays essential roles in virion maturation and infectivity. GP1 is responsible for binding to the cell receptor, and GP2 is a class I fusion protein.
Show More Close

Inquiry

Anti-LASV GP Neutralizing Antibody (V3S-0522-YC7057) (CAT#: V3S-0522-YC7057)

Target: LASV GP

Host Species: Human

Target Species: Lassa mammarenavirus (LASV),

Application: ELISA,Neut,

Inquiry

LASV GP Specific Neutra™ Antibody (V3S-1023-FY89), Human IgG (CAT#: V3S-1023-FY89)

Target: LASV GP

Host Species: Human

Target Species: Lassa mammarenavirus (LASV),

Application: ELISA,Neut (weakly),

For research use only, not directly for clinical use.


banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry